| Product Name | MF | CAS | Details |
|---|
| 6-Nitro-7-Chloro-4-HydroxyQuinazoline | C8H4ClN3O3 | 53449-14-2 | Details |
| (2R,3R)-3-(2,5-Difluorophenyl)-3-hydroxy-2-methyl-4-(1H-1,2,4-triazol-1-yl)thiobutyramide | C13H14F2N4OS | 368421-58-3 | Details |
| Ethyl N-benzyl-3-oxo-4-piperidine-carboxylate hydrochloride | C15H20ClNO3 | 52763-21-0 | Details |
| Regadenoson | C15H18N8O5 | 313348-27-5 | Details |
| 3-(piperidin-4-yl)quinolin-2(1h)-one hydrochloride | C14H17ClN2O | 855778-84-6 | Details |
| 2-(2,5-dichlorobenzamido)acetic acid | C9H7Cl2NO3 | 667403-46-5 | Details |
| 2-Bromo-5-hydroxybenzaldehyde； | C7H5BrO2 | 2973-80-0 | Details |
| 4-CHLORO-3-IODO-PYRIDIN-2-YLAMINE | C5H4ClIN2 | 417721-69-8 | Details |
| Raltitrexed | C21H22N4O6S | 112887-68-0 | Details |
| Pyrido[3,4-d]pyrimidine, 2,4-dichloro-5,6,7,8-tetrahydro-7-(phenylmethyl)- | C14H13Cl2N3 | 1059735-34-0 | Details |
| 4-ChloroMethyl-1-cyclopentyl-2-trifluoroMethyl-benzene | C13H14ClF3 | 957208-65-0 | Details |
| FG-4592 interMediate | C17H13NO4 | 1455091-10-7 | Details |
| 4-(4-Bromo-3-formyl-phenoxy)-benzonitrile； | C14H8BrNO2 | 906673-54-9 | Details |
| 1H-Indole-3-carboxylicacid,6-bromo-4-[(dimethylamino)methyl]-5-hydroxy-1-methyl-2-[(phenylthio)methyl]-,ethyl ester, hydrochloride, hydrate (1:1:1) | C22H28BrClN2O4S | 868364-57-2 | Details |
| 2,4-diamino-6-(hydroxymethyl)-pteridine hydrochloride; | C7H8N6O.HCl.xH2O | 73978-41-3 | Details |
| BOC-PHE-LEU-OME | C21H32N2O5 | 64152-76-7 | Details |
| 1,1,3-Tribromoacetone; | C3H3Br3O | 3475-39-6 | Details |
| Bortezomib | C17H29BF3NO4 | 179324-87-9 | Details |
| 5-Nitrothiophene-2-carboxylicacid | C5H3NO4S | 6317-37-9 | Details |
| 2-Bromo-4'-cyanoacetophenone | C9H6BrNO | 20099-89-2 | Details |
| Alfatinib maleate | C28H29ClFN5O7 | 850140-73-7 | Details |
| 2-(Benzyloxy)-1-broMo-3-nitrobenzene | C13H10BrNO3 | 688363-79-3 | Details |
| Ozenoxacin intermediate | C14H15BN2O3 | 446299-81-6 | Details |
| 6-Bromomethyl-3,4-dihydro-2-methyl-quinazolin-4-one | C10H9BrN2O | 112888-43-4 | Details |
| 3-Aminoisoxazole | C3H4N2O | 1750-42-1 | Details |
| 4-(Methylamino)benzoic acid | C8H9NO2 | 10541-83-0 | Details |
| Methotrexate | C20H22N8O5 | 59-05-2 | Details |
| N-methyl-N-((3R,4R)-4-methylpiperidin-3-yl)-7H-pyrrolo[2,3-d]pyrimidin-4-amin | C13H19N5 | 477600-74-1 | Details |
| 5-chlorothiophene-2-carboxylic acid | C5H3ClO2S | 24065-33-6 | Details |
| 7-BENZYL-5,6,7,8-TETRAHYDROPYRIDO[3,4-D]PYRIMIDINE-2,4(1H,3H)-DIONE | C14H15N3O2 | 62459-02-3 | Details |
| Regorafenib | C21H15ClF4N4O3 | 755037-03-7 | Details |
| N-[4-(Methylamino)benzoyl]-L-glutamic acid zinc salt; | C13H14N2O5Zn | 66104-81-2 | Details |
| 1-(4-Aminophenyl)-4-(4-hydroxyphenyl)piperazine | C16H19N3O | 74853-08-0 | Details |
| 4-(4-aMinophenyl)Morpholin-3-one | C10H12N2O2 | 438056-69-0 | Details |
| 6-Oxabicyclo[3.2.1]octan-7-one, 4-bromo-, (1S-exo)- (9CI) | C7H9BrO2 | 139893-81-5 | Details |
| Lenalidomide | C13H13N3O3 | 191732-72-6 | Details |
| Calcium beta-hydroxy-beta-methylbutyrate | C5H12CaO3 | 135236-72-5 | Details |
| N-isopropyl-2-(3-(4-oxo-3,4-dihydroquinazolin-2-yl)phenoxy)acetamide | C19H19N3O3 | 2121561-39-3 | Details |
| (S)-3-PHENYL-2-[(PYRAZIN-2-YLCARBONYL)AMINO] PROPANOIC ACID | C14H13N3O3 | 114457-94-2 | Details |
| Phosphamycin levophosphorylamine | Details |
| Crisaborole | C14H10BNO3 | 906673-24-3 | Details |
| Isavuconazonium Sulfate | C35H36F2N8O9S2 | 946075-13-4 | Details |
| 4-Hydroxy-1-methyl-7-phenoxy-3-isoquinolinecarboxylic acid methyl ester | C18H15NO4 | 1421312-34-6 | Details |
| Ixazomib Citrate | C20H23BCl2N2O9 | 1239908-20-3 | Details |
| 3-(1-benzyl-1,2,3,6-tetrahydropyridin-4-yl)quinolin-2(1H)-one | C21H20N2O | 783368-14-9 | Details |
| (S)-methyl 2-((S)-2-amino-4-methylpentanamido)-3-phenylpropanoate hydrochloride | C16H25ClN2O3 | 6461-07-0 | Details |
| 2,4-diamino-6-(hydroxymethyl)-pteridine; | C7H8N6O | 945-24-4 | Details |
| 2-Chloro-1-(3,4-difluoro-phenyl)-ethanone | C8H5ClF2O | 51336-95-9 | Details |
| 6-chloro-2-methyl-2H-indazol-5-amine | C8H8ClN3 | 1893125-36-4 | Details |
| 6-(Bromomethyl)-2,4-pteridinediamine hydrobromide; | C7H8Br2N6 | 52853-40-4 | Details |
| 2-Fluoro-5-[(3-oxo-1(3H)-isobenzofuranylidene)methyl]-benzonitrile | C16H8FNO2 | 763114-25-6 | Details |
| Bismuth tripotassium dicitrate | C6H9BiKO7 | 57644-54-9 | Details |
| Calcium folinatc | C20H27CaN7O8 | 6035-45-6 | Details |
| Phentolamine Mesilate | C18H23N3O4S | 65-28-1 | Details |
| Boc-L-homophenylalanine | C15H21NO4 | 100564-78-1 | Details |
| Disodium phosphonomycin | C3H8NaO4P | 26016-99-9 | Details |
| Tribromobenzene | C6H3Br3 | 626-39-1 | Details |
| N-Methyl-4-chloropyridine-2-carboxamide； | C7H7ClN2O | 220000-87-3 | Details |
| 3-Cyclopentylacrylonitrile | C8H11N | 591769-05-0 | Details |
| 1-Methyl-5-amino-1H-benzimidazole-2-butanoic acid ethyl ester | C14H19N3O2 | 3543-73-5 | Details |
| Ozenoxacin | C21H21N3O3 | 245765-41-7 | Details |
| 3-Morpholino-1-(4-nitrophenyl)-5,6-dihydropyridin-2(1H)-one | C15H17N3O4 | 503615-03-0 | Details |
| 3-Morpholino-1-(4-(2-oxopiperidin-1-yl)phenyl)-5,6-dihydropyridin-2(1H)-one | C20H25N3O3 | 545445-44-1 | Details |
| 4-HYDROXY-7-METHOXY-6-NITROQUINAZOLINE | C9H7N3O4 | 1012057-47-4 | Details |
| 5-AMINOINDAZOLE | C7H7N3 | 19335-11-6 | Details |
| Ozenoxacin intermediate | C16H17Cl2NO3 | 103877-38-9 | Details |
| Mizoribine | C9H13N3O6 | 50924-49-7 | Details |
| Methyl 2-(4-methylphenylsulfonamido)acetate | C10H13NO4S | 2645-02-5 | Details |
| 2,6-Dioxopiperidine-3-ammonium chloride | C5H9ClN2O2 | 24666-56-6 | Details |
| 4-(3-chloro-4-fluoro-phenylamino)-7-chloro-6-nitroquinazoline | C14H7Cl2FN4O2 | 179552-73-9 | Details |
| Glycine, N-[(1,1-diMethylethoxy)carbonyl]-N-Methyl-, [2-[[(1-chloroethoxy)carbonyl]MethylaMino]-3-pyridinyl]Methyl ester | C18H26ClN3O6 | 338990-31-1 | Details |
| Finerenone | C21H22N4O3 | 1050477-31-0 | Details |
| 1-(1-Methyl-4-piperidinyl)piperazine | C10H21N3 | 23995-88-2 | Details |
| 3-fluoro-4-aminophenol | C6H6FNO | 399-95-1 | Details |
| Methyl 2-bromomethyl-3-nitrobenzoate | C9H8BrNO4 | 98475-07-1 | Details |
| Abiraterone acetate | C26H33NO2 | 154229-18-2 | Details |
| Ruxolitinib Phosphate | C17H21N6O4P | 1092939-17-7 | Details |
| Roxadustat | C19H16N2O5 | 808118-40-3 | Details |
| Baricitinib | C16H17N7O2S | 1187594-09-7 | Details |
| 4-Chloro-3-(trifluoromethyl)phenyl isocyanate | C8H3ClF3NO | 327-78-6 | Details |
| Morinidazole | C11H18N4O4 | 92478-27-8 | Details |
| 5-[N-(tert-butoxycarbonyl)-N-methylamino]-2-thiophenecarboxylic acid | C11H15NO4S | 131052-68-1 | Details |
| trans-4-Dimethylaminocrotonic acid hydrochloride | C6H12ClNO2 | 848133-35-7 | Details |
| Belumosudil mesylate | C27H28N6O5S | 2109704-99-4 | Details |
| Methotrexate disodium salt; | C20H23N8NaO5 | 7413-34-5 | Details |
| Fosfomycin calcium | C3H5O4P.Ca | 26472-47-9 | Details |
| 4-Chloro-3-nitro-5-sulphamoylbenzoic acid | C7H5ClN2O6S | 22892-96-2 | Details |
| Sorafenib Tosylate | C21H16ClF3N4O3.C7H8O3S | 475207-59-1 | Details |
| Sorafenib Tosylate | C21H16ClF3N4O3 | 284461-73-0 | Details |
| 2'-Methoxy-3'-nitro-biphenyl-3-carboxylic acid | C14H11NO5 | 376591-94-5 | Details |
| Letrozole | C17H11N5 | 112809-51-5 | Details |
| ethyl 2-(7-hydroxy-1,2,3,4-tetrahydrocyclopenta[b]indol-3-yl)acetate(WXG02032) | C15H17NO3 | 1206124-13-1 | Details |
| Fosfomycin tromethamine | C7H18NO7P | 78964-85-9 | Details |
| Bumetanide | C17H20N2O5S | 28395-03-1 | Details |
| 6-(chloromethyl)pteridine-2,4-diamine monohydrochloride; | C7H8Cl2N6 | 82778-08-3 | Details |
| Product Total： Product Page： | ||||
| 1 2 | ||||